Profund Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$544K Buy
31,789
+10,161
+47% +$174K 0.02% 444
2025
Q1
$1.38M Sell
21,628
-389
-2% -$24.8K 0.06% 234
2024
Q4
$2.68M Sell
22,017
-6,358
-22% -$773K 0.1% 142
2024
Q3
$3.54M Buy
28,375
+78
+0.3% +$9.74K 0.13% 113
2024
Q2
$4.47M Buy
28,297
+17,132
+153% +$2.71M 0.17% 90
2024
Q1
$1.45M Sell
11,165
-5,112
-31% -$662K 0.06% 243
2023
Q4
$1.57M Buy
16,277
+4,087
+34% +$394K 0.07% 235
2023
Q3
$1.48M Buy
12,190
+638
+6% +$77.3K 0.08% 191
2023
Q2
$1.32M Buy
11,552
+2,960
+34% +$339K 0.07% 248
2023
Q1
$1.18M Sell
8,592
-1,200
-12% -$165K 0.07% 262
2022
Q4
$1.27M Buy
9,792
+243
+3% +$31.5K 0.08% 214
2022
Q3
$1.06M Sell
9,549
-449
-4% -$49.7K 0.08% 236
2022
Q2
$749K Sell
9,998
-850
-8% -$63.7K 0.05% 322
2022
Q1
$847K Sell
10,848
-1,127
-9% -$88K 0.04% 365
2021
Q4
$1.08M Sell
11,975
-975
-8% -$87.8K 0.04% 312
2021
Q3
$1.2M Sell
12,950
-665
-5% -$61.5K 0.04% 303
2021
Q2
$1.06M Sell
13,615
-377
-3% -$29.3K 0.04% 344
2021
Q1
$1.04M Sell
13,992
-2,088
-13% -$156K 0.04% 305
2020
Q4
$2.74M Buy
16,080
+1,484
+10% +$253K 0.12% 155
2020
Q3
$2.05M Sell
14,596
-1,823
-11% -$256K 0.11% 171
2020
Q2
$2.63M Buy
16,419
+3,115
+23% +$500K 0.15% 124
2020
Q1
$1.3M Sell
13,304
-4,854
-27% -$475K 0.1% 182
2019
Q4
$2.34M Buy
18,158
+1,905
+12% +$246K 0.1% 174
2019
Q3
$1.22M Sell
16,253
-918
-5% -$69.1K 0.06% 284
2019
Q2
$2.61M Sell
17,171
-1,295
-7% -$197K 0.12% 151
2019
Q1
$2.2M Buy
18,466
+248
+1% +$29.6K 0.11% 180
2018
Q4
$1.99M Sell
18,218
-3,125
-15% -$341K 0.12% 152
2018
Q3
$3.45M Buy
+21,343
New +$3.45M 0.13% 127